Digbi Health Added Hormone Therapy to Telehealth Platform
The company expanded its precision biology services to offer personalized hormone replacement therapy for members.
Updated on Oct. 2, 2026 in Women’s Health
Live Poll
Do you believe consolidating multiple healthcare services into one app provides better health outcomes for patients?
Digbi Health has integrated hormone replacement therapy into its precision biology telehealth platform. The service uses genetic, gut microbiome, and blood-biomarker data to deliver personalized care for women navigating menopause.
Why it matters
The platform expansion addresses the frequent co-occurrence of hormonal, metabolic, and gastrointestinal conditions in women. By consolidating multiple health programs onto one system, employers can eliminate redundant fees for standalone services.
An actuarial claims analysis documented a $3,012 reduction in annual healthcare expenditures per member across seven self-insured employers. Currently, 75% of Digbi female members aged 40 to 60 have an obesity, cardiometabolic, or gastrointestinal diagnosis.
The players
Digbi Health
This Mountain View-based company provides a precision biology platform that combines digital health tracking with AI-driven analysis of genetic and microbiome data.
The details
The platform identifies and addresses specific risks to bone and cardiovascular health common in postmenopausal women. Digbi Health currently partners with more than 300 employers and health plans, granting approximately 30 million individuals access to its services.
Timeline
October 2, 2026: Digbi Health announced the platform expansion.
2027: Employers will begin incorporating the new services into their plan designs.
Health Landscape
This integration follows the pattern of employers increasingly utilizing digital health platforms to manage rising costs associated with chronic disease management and preventive care, similar to the broader trend seen following the Affordable Care Act's preventive services coverage mandates.
Women aged 40 to 60 may soon have access to hormone replacement therapy that is personalized using their own genetic and biomarker data. This integration allows patients to manage complex co-occurring conditions, such as gastrointestinal and cardiometabolic issues, through a single coordinated platform.
The takeaway
Consolidating health services can lead to significant cost savings for self-insured employers while providing more targeted care for employees. Patients should check if their company's 2027 benefits package includes access to these precision biology programs.
What happens next
Employers are scheduled to integrate these new hormone replacement services into their health plan designs throughout 2027.
Further reading
For more information on innovations in care, visit the Women’s Health section.
Live Poll
Do you believe consolidating multiple healthcare services into one app provides better health outcomes for patients?
